DAVIDavion Healthcare (Direct Listing)

US ExchangeHealth Care2026-10-22

Irish PLC developing and commercializing non-invasive home diagnostic tests for early detection of health anomalies, including cancers.

$12IPO price

$300MRaised

$11.65Day-1 close

-2.92%Day-1 return

Irish PLC developing and commercializing non-invasive home diagnostic tests for early detection of health anomalies, including cancers.

Company description (source: StockAnalysis)

Davion Healthcare Plc is an Irish Public Limited Company focused exclusively on the development and commercialization of non-invasive home diagnostic tests for the early detection of health anomalies, including cancers. Our products are classified as Class I medical devices and are fully registered with regulatory authorities in the United States (FDA), the European Union (CE mark), and the United Kingdom (UKCA). Our flagship product, BreastCheck, is a non-invasive home test designed to detect temperature anomalies in breast tissue, which may b...

医疗器械体外诊断家庭健康

51CFO read: Requires IVD regulatory pathway expertise, direct listing financial disclosure fluency, and cross-market (FDA/CE/UKCA) compliance finance ov

Management details per the SEC prospectus.

Company profile SEC prospectus

Does your company need this kind of CFO?

51CFO is an investment banking team focused on the US market: US IPOs, reverse mergers, shell deals, SPAC and De-SPAC, SEC filings and post-listing follow-ons, run by one team from structure to opening bell. Free 30-minute listing-route diagnosis, answered within 24 hours.

Talk to us